Measurement of antioxidant capacity using the biological antioxidant potential test and its role as a predictive marker of metabolic syndrome

Korean Journal of Internal Medicine

Volumn 29, Issue 1, 2014, Pages 31-39

  Kim, Jung Hee ^a   Baik, Hyun Wook ^a   Yoon, Yeong Sook ^b   Joung, Hyo Jee ^c   Park, Ju Sang ^a   Park, Sang Jong ^a   Jang, Eun Jeong ^a   Park, Sang Woon ^a   Kim, Sang Jung ^a   Kim, Mi Jeoung ^a   Jeon, Dong Ok ^a   Cho, Hyo Jin ^a   Lee, Sang Jin ^a   Im, Sung Gyu ^a   Jang, Sun Kyung ^a  

^a Bundang Jesaeng Hospital   (South Korea)

^b Inje University   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Adiponectin; Insulin; Metabolic syndrome; Oxidative stress

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN; INSULIN; INTERLEUKIN 6; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; ADIPOCYTOKINE; ANTIOXIDANT; IL6 PROTEIN, HUMAN;

ADULT; ANALYTIC METHOD; ANTIOXIDANT ASSAY; ARTICLE; BIOLOGICAL ANTIOXIDANT POTENTIAL TEST; BODY MASS; COLORIMETRY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; INSULIN RESISTANCE; LINEAR REGRESSION ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OXIDATIVE STRESS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; BLOOD; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED; PREDICTIVE VALUE;

ADIPOKINES; ADULT; ANTIOXIDANTS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; INTERLEUKIN-6; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84894623701     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2014.29.1.31     Document Type: Article

References (32)

1. Sharma P, Mishra S, Ajmera P, Mathur S. Oxidative stress in metabolic syndrome. Indian J Clin Biochem 2005;20:145-149.
2. Lim S, Shin H, Song JH, et al. Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998-2007. Diabetes Care 2011;34:1323-1328.
3. Ko KS, Rhee BD. Insulin resistance and metabolic syndrome. J Korean Diabetes Assoc 2005;29:501-506.
4. Mohamed-Ali V, Goodrick S, Rawesh A, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997;82:4196-4200.
5. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993;259:87-91.
6. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994;15:74-80.
7. Imperatore G, Riccardi G, Iovine C, Rivellese AA, Vaccaro O. Plasma fibrinogen: a new factor of the metabolic syndrome: a population-based study. Diabetes Care 1998;21:649-654.
8. Rifai N. High-sensitivity C-reactive protein: a useful marker for cardiovascular disease risk prediction and the metabolic syndrome. Clin Chem 2005;51:504-505.
9. Lee WY, Park JS, Sung KC, et al. Relationship between metabolic syndrome, insulin resistance and C-reactive protein in urban Korean adult population. Korean J Med 2003;64:169-177.
10. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004;24:29-33.
11. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 2001;30:1191-1212.
12. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inf lammation, and cancer: how are they linked? Free Radic Biol Med 2010;49:1603-1616.
13. Roberts CK, Sindhu KK. Oxidative stress and metabolic syndrome. Life Sci 2009;84:705-712.
14. Ford ES, Mokdad AH, Giles WH, Brown DW. The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes 2003;52:2346-2352.
15. Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004;114:1752-1761.
16. Skalicky J, Muzakova V, Kandar R, Meloun M, Rousar T, Palicka V. Evaluation of oxidative stress and inflammation in obese adults with metabolic syndrome. Clin Chem Lab Med 2008;46:499-505.
17. Kwak HK, Yoon S. Relation of serum total antioxidant status with metabolic risk factors in Korean adults. Nutr Res Pract 2007;1:335-340.
18. Eugenio LI. Fundamental principles, signif icance and clinical application of oxidative stress assessment (d-ROMs, BAP and other Carratelli's panel test). Paper presented at: The 1st Korea Free Radicals and Antioxidants Seminar; 2011 Sep 18; Incheon, Korea.
19. Lee SY, Park HS, Kim DJ, et al. Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract 2007;75:72-80.
20. Vassalle C, Pratali L, Boni C, Mercuri A, Ndreu R. An oxidative stress score as a combined measure of the pro-oxidant and anti-oxidant counterparts in patients with coronary artery disease. Clin Biochem 2008;41:1162-1167.
21. Hansel B, Giral P, Nobecourt E, et al. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab 2004;89:4963-4971.
22. Vekic J, Kotur-Stevuljevic J, Zeljkovic A, Stefanovic A, Bogavac-Stanojevic N, Vujovic A. Oxidative stress, HDL and atherosclerosis. Antiinf lamm Antiallergy Agents Med Chem 2008;7:158-165.
23. Miri R, Saadati H, Ardi P, Firuzi O. Alterations in oxidative stress biomarkers associated with mild hyperlipidemia and smoking. Food Chem Toxicol 2012;50:920-926.
24. Abdilla N, Tormo MC, Fabia MJ, Chaves FJ, Saez G, Redon J. Impact of the components of metabolic syndrome on oxidative stress and enzymatic antioxidant activity in essential hypertension. J Hum Hypertens 2007;21:68-75.
25. Chaves FJ, Mansego ML, Blesa S, et al. Inadequate cytoplasmic antioxidant enzymes response contributes to the oxidative stress in human hypertension. Am J Hypertens 2007;20:62-69.
26. Ikebuchi M, Nishio Y, Maegawa H, Kashiwagi A. Effects of hyperglycemia on oxidative stress and antioxidant potential in patients with type 2 diabetes. Diabetol Int 2010;1:72-77.
27. Ridker PM, Wilson PW, Grundy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 2004;109:2818-2825.
28. Bahceci M, Gokalp D, Bahceci S, Tuzcu A, Atmaca S, Arikan S. The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6 and high sensitivity C-reactive protein levels: is adipocyte size associated with inflammation in adults? J Endocrinol Invest 2007;30:210-214.
29. You T, Nicklas BJ, Ding J, et al. The metabolic syndrome is associated with circulating adipokines in older adults across a wide range of adiposity. J Gerontol A Biol Sci Med Sci 2008;63:414-419.
30. Holvoet P, Lee DH, Steffes M, Gross M, Jacobs DR Jr. Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. JAMA 2008;299:2287-2293.
31. Katsuki A, Suematsu M, Gabazza EC, et al. Increased oxidative stress is associated with decreased circulating levels of adiponectin in Japanese metabolically obese, normal-weight men with normal glucose tolerance. Diabetes Res Clin Pract 2006;73:310-314.
32. Vassalle C, Masini S, Carpeggiani C, L'Abbate A, Boni C, Zucchelli GC. In vivo total antioxidant capacity: comparison of two different analytical methods. Clin Chem Lab Med 2004;42:84-89.